Larvol Delta - aTyr-Pharma-Announces-Positive-Topline-Results-from-Phase-2-Clinical-Trial-of-ATYR1923-in-COVID19-Patients-with-Severe-Respiratory-Complications

Stalaris (ATYR1923) - aTyr Pharma, Kyorin

http://www.globenewswire.com/news-release/2021/01/04/2152952/0/en/aTyr-Pharma-Announces-Positive-Topline-Results-from-Phase-2-Clinical-Trial-of-ATYR1923-in-COVID-19-Patients-with-Severe-Respiratory-Complications.html

Jan 4, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next